Navigation Links
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Date:5/4/2009

rican Cystic Fibrosis conference in Minneapolis in October.

Bronchitol has received Orphan Drug Designation and development fast track status from the U.S. Food and Drug Administration and Orphan Drug Designation from the European Medicines Agency.

Bronchitol is designed to hydrate the airway surface of the lungs, and promote normal lung mucus clearance. No new products have been approved anywhere in the world for cystic fibrosis for more than 10 years.

Dr Alan Robertson said: "We recognise that many people have been involved in the development of Bronchitol and their assistance has been invaluable. The trial was complex and challenging and this landmark result is a tribute to their efforts."

Dr Alan Robertson will host a teleconference to discuss the results on Tuesday 5th May at 8.00am (Sydney), (Monday 4th May at 6.00pm U.S. East Coast, 3.00pm U.S. West Coast).

    Telephone access (toll free) details are below:

    -- Australia: 1800 131 617
    -- USA/Canada:  866 746 2596
    -- UK: 0800 376 8339
    -- NZ: 0800 446 958
    -- Switzerland: 0800 001 230
    Online (global access):
http://services.choruscall.com/links/pharmaxis090505.html

About Pharmaxis

Pharmaxis (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory and immune disorders. Its development pipeline of products includes Aridol for the diagnosis of asthma, Bronchitol for cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease (COPD), PXS25 for the treatment of lung fibrosis and PXS4159 for asthma. Founded in 1998, Pharmaxis is listed on the Australian Securities Exchange (symbol PXS), and on NASDAQ Global Market (symbol PXSL). The company is headquartered in Sydn
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
2. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
3. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
4. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
5. Pharmaxis Establishes Named Patient Program for Bronchitol
6. Pharmaxis Long-Term Safety Study of Bronchitol Completes
7. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
8. Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
9. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
10. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
11. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... and conference call with investors to July 31, 2014 ... Company rescheduled the release date and conference call to ... Hideo Watanabe , President of STAAR Japan, who ...
(Date:7/28/2014)... MDXG ), an integrated developer, processor and marketer ... amniotic membrane, announced today its results for the quarter ended ... Revenue exceeds upper end of guidance and increases by ... Quarter-over-quarter revenue grew by 31% , ... and 40% sequentially over Q1 2014 , ...
(Date:7/28/2014)... N.J. , July 28, 2014   ... $520,000 settlement of off-label marketing and fraud claims ... and Vascular Solutions, Inc. ("VSI").  The settlement covers ... medical devices for endovenous laser ablation of varicose ... Magnanini, a firm with a history of representing ...
Breaking Medicine Technology:STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3
... 15, 2011 Reportlinker.com announces that ... available in its catalogue: ... Facial Aesthetics and Medical Laser Devices ... The combined ...
... 2011 /PRNewswire-iReach/ -- URINOZINC® Prostate Formula ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) The original, ... all corporate-owned GNC Live Well stores and at ... has more than 6,000 stores spread over 49 ...
Cached Medicine Technology:Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 2Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 3Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 4Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 5Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 6Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 7Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 8Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 9Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 10Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 11Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 12Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 13Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 14Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 15Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 16Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3
(Date:7/29/2014)... The Multiple System Atrophy Coalition, a growing ... of five new members to its Board of Directors. ... of its executive directors. The MSA Coalition now ... Physician Advisors. These 12 dedicated volunteers are fully ... support, advocacy and research funding for the neurological disorder ...
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 ... 3.1 out of 5. This score reflects a buyer's ... of the large number of suppliers, the product's widespread ... market, says IBISWorld analyst Jordan Weinstein. IBISWorld estimates that ... with a substantial number of supplier options. However, recent ...
(Date:7/29/2014)... Ticketability.com has reduced the cost of Phantom of ... lower prices on the secure website. Customers are invited to ... tickets that are priced lower every day. , Click ... Ticketability.com. , Theatergoers know that attending an entertaining show can ... the Opera tickets for sale that are priced to fit ...
(Date:7/28/2014)... gene controlling red blood cell development have spread from ... according to a new study led by King,s College ... populations to look for the origin of changes in ... into adulthood. Fetal haemoglobin is normally found in fetuses ... who are able to keep making it as adults ...
(Date:7/28/2014)... Anapolis, MD (PRWEB) July 28, 2014 Evolve ... July 16, 2014, offering its members virtual visits and dramatic ... care. , Some estimates state that as many as ... conducted virtually. “Imagine not having to leave your office or ... on your blood pressure or cholesterol,” CEO and Founder Michael ...
Breaking Medicine News(10 mins):Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 2Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 4
... Patients to Provide Direct Feedback ... and Award Nurses for Compassionate Care, ... of Interactive Patient Care (IPC) solutions, today announced that,it ... recognize the,exceptional work of nurses through the DAISY Award ...
... 2, 2008) - In an article featured on the ... Ferrari, Ph.D., of The University of Texas Health Science ... new multistage delivery system (MDS) for imaging and therapeutic ... making injectable drugs more effective. The study is included ...
... nano-sensor for better detection of Mad Cow Disease agent, ... food safety, researchers in New York are reporting development ... of the deadly prion proteins that cause Mad Cow ... detects binding of prion proteins by detecting frequency changes ...
... develops tool to test for kids who may have this ... working memory, rather than low intelligence, could be the reason ... study. , Working memory is the ability to retain and ... aid of pen and paper or a calculator. Students need ...
... Inc.,(Nasdaq: IWOV ), a global leader in ... a joint session with Blue Cross Blue Shield,of ... Conference,on March 6th at 12 noon at the ... http://www.newscom.com/cgi-bin/prnh/20071205/INTWOVLOGO ), The session, entitled "Putting Content ...
... (NYSE: T ),announced today the deployment of ... and mobile broadband access for the customers at,Thomas ... committed to excellence in patient care," said Stephen,Tranquillo, ... at every level is vital to the patient ...
Cached Medicine News:Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 2Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 3Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 4Health News:Nanomedicine system engineered to enhance therapeutic effects of injectable drugs 2Health News:Nanomedicine system engineered to enhance therapeutic effects of injectable drugs 3Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 2Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 3Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 4Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 5Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 6Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 7Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 8Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 9Health News:Poor Working Memory Tied to Low School Scores 2Health News:Blue Cross Blue Shield of Massachusetts and Interwoven to Present at 2008 AIIM International Exposition and Conference 2Health News:AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital 2Health News:AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital 3
... Eye is based on a powerful, easy-to-use ... serve the specific treatment and business requirements ... office.,Designed to provide patient care assistance as ... is accurate, AllMeds for Eye's simple "point ...
... an Electronic Medical Office (EMO) for the ... of your practice. In addition to retrieving ... electronically integrates the patient office flow including ... and billing information. ChartLogic also gives you ...
... from Laboratory Data Systems, Inc is the first ... to the specific needs of POC (managed from ... Care or Lab). The design of AegisPOC ensures ... to manage their testing programs in the manner ...
...
Medicine Products: